Cargando…

Interaction of Fabry Disease and Diabetes Mellitus: Suboptimal Recruitment of Kidney Protective Factors

Fabry disease is a lysosomal disease characterized by globotriaosylceramide (Gb3) accumulation. It may coexist with diabetes mellitus and both cause potentially lethal kidney end-organ damage. However, there is little information on their interaction with kidney disease. We have addressed the intera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanchez-Niño, Maria D., Ceballos, Maria I., Carriazo, Sol, Pintor-Chocano, Aranzazu, Sanz, Ana B., Saleem, Moin A., Ortiz, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650640/ https://www.ncbi.nlm.nih.gov/pubmed/37958836 http://dx.doi.org/10.3390/ijms242115853

Ejemplares similares

Increased expression of SCARF genes favoring SARS-CoV-2 infection in key target organs in CKD
por: Carriazo, Sol, et al.
Publicado: (2023)

Stopping kidney protection in the elderly following acute kidney injury: think mortality
por: Carriazo, Sol, et al.
Publicado: (2022)

Gender, Albuminuria and Chronic Kidney Disease Progression in Treated Diabetic Kidney Disease
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2020)

SCARF Genes in COVID-19 and Kidney Disease: A Path to Comorbidity-Specific Therapies
por: Carriazo, Sol, et al.
Publicado: (2023)

European East–West divide in kidney disease: the need to understand the drivers of chronic kidney disease outcomes
por: Carriazo, Sol, et al.
Publicado: (2020)

The last pre-pandemic European Renal Association Registry report: age at start of kidney replacement therapy in Europe
por: Carriazo, Sol, et al.
Publicado: (2021)

More on the invisibility of chronic kidney disease… and counting
por: Carriazo, Sol, et al.
Publicado: (2021)

Kidney disease and electrolytes in COVID-19: more than meets the eye
por: Carriazo, Sol, et al.
Publicado: (2020)

Nicotinamide and acute kidney injury
por: Fontecha-Barriuso, Miguel, et al.
Publicado: (2021)

Chronodisruption: A Poorly Recognized Feature of CKD
por: Carriazo, Sol, et al.
Publicado: (2020)

Tirzepatide and prevention of chronic kidney disease
por: Bosch, Catalina, et al.
Publicado: (2022)

Solving the riddle of Aguascalientes nephropathy: nephron number, environmental toxins and family clustering
por: Villalvazo, Priscila, et al.
Publicado: (2022)

Aguascalientes: one of the hottest chronic kidney disease (CKD) hotspots in Mexico and a CKD of unknown aetiology mystery to be solved
por: Villalvazo, Priscila, et al.
Publicado: (2021)

Wasp stings and plasma exchange
por: Carriazo, Sol, et al.
Publicado: (2022)

Dietary Care for ADPKD Patients: Current Status and Future Directions
por: Carriazo, Sol, et al.
Publicado: (2019)

Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrology
por: Carriazo, Sol, et al.
Publicado: (2020)

Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
por: Martinez-Moreno, Julio M., et al.
Publicado: (2020)

Lyso-Gb3 Increases αvβ3 Integrin Gene Expression in Cultured Human Podocytes in Fabry Nephropathy
por: Trimarchi, Hernán, et al.
Publicado: (2020)

Fibrosis: a key feature of Fabry disease with potential therapeutic implications
por: Weidemann, Frank, et al.
Publicado: (2013)

Who killed Bruce Lee? The hyponatraemia hypothesis
por: Villalvazo, Priscila, et al.
Publicado: (2022)

The dirty little secret of urate-lowering therapy: useless to stop chronic kidney disease progression and may increase mortality
por: Gonzalez-Martin, Guillermo, et al.
Publicado: (2020)

Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normal
por: Rojas-Rivera, Jorge Enrique, et al.
Publicado: (2019)

Tacrolimus Prevents TWEAK-Induced PLA2R Expression in Cultured Human Podocytes
por: Cuarental, Leticia, et al.
Publicado: (2020)

Blood pressure targets in CKD 2021: the never-ending guidelines debacle
por: Carriazo, Sol, et al.
Publicado: (2022)

Psoas Abscess Formation in Suboptimally Controlled Diabetes Mellitus
por: Lansdown, A. J., et al.
Publicado: (2011)

Regulated cell death pathways in kidney disease
por: Sanz, Ana B., et al.
Publicado: (2023)

Dysregulated Autophagy Contributes to Podocyte Damage in Fabry’s Disease
por: Liebau, Max C., et al.
Publicado: (2013)

MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapy
por: Fernandez-Prado, Raul, et al.
Publicado: (2019)

ERT impact on left ventricular mass in Fabry disease
por: Ortiz, Alberto
Publicado: (2019)

Suboptimal personal protective equipment and SARS-CoV-2 infection in Nephrologists: a Spanish national survey
por: Quiroga, Borja, et al.
Publicado: (2021)

Phosphate, Microbiota and CKD
por: Favero, Chiara, et al.
Publicado: (2021)

Diagnosing Fabry nephropathy: the challenge of multiple kidney disease
por: Esposito, Pasquale, et al.
Publicado: (2023)

Expression of uPAR in Urinary Podocytes of Patients with Fabry Disease
por: Trimarchi, Hernán, et al.
Publicado: (2017)

Fabry disease: the many faces of a single disorder
por: Torra, Roser, et al.
Publicado: (2012)

Receptor-Mediated Endocytosis of α-Galactosidase A in Human Podocytes in Fabry Disease
por: Prabakaran, Thaneas, et al.
Publicado: (2011)

Probiotics for kidney disease
por: Favero, Chiara, et al.
Publicado: (2022)

Gain-of-function TLR7 and loss-of-function A20 gene variants identify a novel pathway for Mendelian lupus and lupus nephritis
por: Villalvazo, Priscila, et al.
Publicado: (2022)

CD74 in Kidney Disease
por: Valiño-Rivas, Lara, et al.
Publicado: (2015)

Outcomes of Kidney Transplantation in Fabry Disease: A Meta-Analysis
por: Suarez, Maria L. Gonzalez, et al.
Publicado: (2020)

Clinical proteomics in kidney disease as an exponential technology: heading towards the disruptive phase
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rdvsinqgaehpbu4d30e626gipu